Professor Johan Rockberg is a leading researcher at KTH Royal Institute of Technology, where he specializes in antibody engineering, protein design, and biotechnology. His work focuses on developing next-generation biopharmaceuticals that have applications in treating diseases like cancer. With a background in engineering biology and extensive expertise in molecular biosciences, he leads research aimed at designing customized proteins and antibodies that can be produced efficiently and tailored to individual patients’ needs.

Professor Rockberg’s research combines advanced biotechnological techniques with a strong focus on scalability and precision, striving to make innovative therapies both effective and widely accessible. His collaborative projects, often involving academic, healthcare, and industry partners, are dedicated to advancing personalized medicine by creating adaptable and efficient drug platforms.